Metabolic syndrome (more specifically obesity) can cause a decrease in Bifidobacterium levels and lead to a reduced production of Glucagon-like peptide-2 (GLP-2), which is vital for the maintenance of intestinal barrier function. The gene discussed is GCG; the disease is obesity disorder.